| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing towards precision medicine in ARDS
|
Gilbert, Judith A
|
|
|
6 |
7 |
p. 494-495
|
artikel
|
| 2 |
2018 American Thoracic Society International Conference
|
Akkermans, Rebecca
|
|
|
6 |
7 |
p. 489-491
|
artikel
|
| 3 |
Childhood origins of COPD
|
von Mutius, Erika
|
|
|
6 |
7 |
p. 482-483
|
artikel
|
| 4 |
Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life
|
Bui, Dinh S
|
|
|
6 |
7 |
p. 535-544
|
artikel
|
| 5 |
Corrections
|
|
|
|
6 |
7 |
p. e35
|
artikel
|
| 6 |
Designing trials for new cystic fibrosis modulators
|
Cunningham, Steve
|
|
|
6 |
7 |
p. 484-486
|
artikel
|
| 7 |
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
|
Russell, Richard J
|
|
|
6 |
7 |
p. 499-510
|
artikel
|
| 8 |
Evolving management and patient choice in pulmonary alveolar proteinosis
|
Munsif, Maitri
|
|
|
6 |
7 |
p. e35
|
artikel
|
| 9 |
Global challenges for respiratory health-care access and quality
|
Venkatesan, Priya
|
|
|
6 |
7 |
p. 491
|
artikel
|
| 10 |
Hypoxia and eosinophilia in a patient with difficult asthma
|
McBrien, Claire
|
|
|
6 |
7 |
p. 566
|
artikel
|
| 11 |
Isoniazid-resistant, rifampicin-susceptible tuberculosis in India
|
Mittal, Saurabh
|
|
|
6 |
7 |
p. e29
|
artikel
|
| 12 |
Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study
|
Rosenfeld, Margaret
|
|
|
6 |
7 |
p. 545-553
|
artikel
|
| 13 |
Lung function trajectories from pre-school age to adulthood and their associations with early life factors: a retrospective analysis of three population-based birth cohort studies
|
Belgrave, Danielle C M
|
|
|
6 |
7 |
p. 526-534
|
artikel
|
| 14 |
Pan-tuberculosis regimens: re-framing the argument
|
Gupta, Rajesh
|
|
|
6 |
7 |
p. e28
|
artikel
|
| 15 |
Populations under siege and in prison require investment from Syria's national tuberculosis programme
|
Abbara, Aula
|
|
|
6 |
7 |
p. e34
|
artikel
|
| 16 |
Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach
|
Kumar, Anupam
|
|
|
6 |
7 |
p. 554-565
|
artikel
|
| 17 |
Pulmonary tuberculosis in Pope Clement XI
|
Riva, Michele Augusto
|
|
|
6 |
7 |
p. 497-498
|
artikel
|
| 18 |
Respiratory health in Italy
|
Burki, Talha
|
|
|
6 |
7 |
p. 492-493
|
artikel
|
| 19 |
RSV prevention in infancy and asthma in later life
|
Carbonell-Estrany, Xavier
|
|
|
6 |
7 |
p. e31
|
artikel
|
| 20 |
RSV prevention in infancy and asthma in later life
|
Simões, Eric A F
|
|
|
6 |
7 |
p. e30
|
artikel
|
| 21 |
RSV prevention in infancy and asthma in later life
|
Dupont, William
|
|
|
6 |
7 |
p. e32
|
artikel
|
| 22 |
RSV prevention in infancy and asthma in later life – Authors' reply
|
Scheltema, Nienke M
|
|
|
6 |
7 |
p. e33
|
artikel
|
| 23 |
Swabbing for science
|
Kasmauski, Karen
|
|
|
6 |
7 |
p. 497
|
artikel
|
| 24 |
The death of low-dose oral theophylline for COPD?
|
The Lancet Respiratory Medicine,
|
|
|
6 |
7 |
p. 479
|
artikel
|
| 25 |
Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials
|
Panettieri Jr, Reynold A
|
|
|
6 |
7 |
p. 511-525
|
artikel
|
| 26 |
Tralokinumab unsuccessful for management of severe, uncontrolled asthma
|
Chung, Kian Fan
|
|
|
6 |
7 |
p. 480-481
|
artikel
|
| 27 |
Treatment of cystic fibrosis in infants
|
Accurso, Frank J
|
|
|
6 |
7 |
p. 483-484
|
artikel
|
| 28 |
Use of a rare disease patient registry in long-term post-authorisation drug studies: a model for collaboration with industry
|
Bilton, Diana
|
|
|
6 |
7 |
p. 495-496
|
artikel
|
| 29 |
Would pan-tuberculosis treatment regimens be cost-effective?
|
Kendall, Emily A
|
|
|
6 |
7 |
p. 486-488
|
artikel
|
Tijdschrift beschrijving